The relationship between dysphonia and dysarthria in FRDA suggests that reducing overall dysphonia severity via therapeutic techniques that improve phonatory stability and increase speaking rate is a viable target for clinical trials

J Voice. 2017 Mar;31(2):243.e9-243.e19. doi: 10.1016/j.jvoice.2016.04.015